Cameron Turtle, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 5,000 shares at $47.00 ($235K) on 2020-11-24, disclosed to the SEC on 2020-11-25.
Open-market sale of $235k BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.00 | 4,258 | $200K | 85.1% |
| 2 | $47.23 | 742 | $35K | 14.9% |
| Total | $47.03 avg | 5,000 | $235K | 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $1.4M | — | Filing → |
| SYRE | SELL | 2026-07-02 | $1.3M | — | Filing → |
| SYRE | SELL | 2026-06-03 | $1.1M | — | Filing → |